January 30, 2019
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Read More
January 30, 2019
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation
Read More
January 30, 2019
“Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC”
Read More
January 30, 2019
“Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC”
Read More
January 30, 2019
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy
Read More
January 30, 2019
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Read More
January 30, 2019
Antifungal Use in Oncohematological Neutropenic Patients
Read More
January 30, 2019
Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Read More
January 30, 2019
Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Read More
January 30, 2019
Register of Telaprevir and Boceprevir in Routine Clinical Practice
Read More
January 30, 2019
Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)
Read More
December 10, 2018
Adalimumab Intralesional in Intestinal Strictures of Crohn’s Disease Patients
Read More
Load More
X